2000

1. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial

   Human Reproduction, Vol. 15, Núm. 7, pp. 1490-1498